KRTAP2-2
gene geneOn this page
Also known as KAP2.2
Summary
KRTAP2-2 (keratin associated protein 2-2, HGNC:18905) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 2-2 (Q9BYT5). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 728279 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_033032
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18905 |
| Approved symbol | KRTAP2-2 |
| Name | keratin associated protein 2-2 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP2.2 |
| Ensembl gene | ENSG00000214518 |
| Ensembl biotype | protein_coding |
| Entrez | 728279 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000398477
RefSeq mRNA: 1 — MANE Select: NM_033032
NM_033032
CCDS: CCDS54122
Canonical transcript exons
ENST00000398477 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533294 | 41054498 | 41055230 |
Expression profiles
Bgee: expression breadth broad, 35 present calls, max score 42.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1670 / max 22.1598, expressed in 71 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165868 | 0.1116 | 43 |
| 165869 | 0.0554 | 20 |
Top tissues by expression
106 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 42.16 | gold quality |
| zone of skin | UBERON:0000014 | 39.95 | gold quality |
| right lung | UBERON:0002167 | 39.81 | gold quality |
| skin of leg | UBERON:0001511 | 38.62 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| liver | UBERON:0002107 | 31.05 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| right lobe of liver | UBERON:0001114 | 29.56 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.21 | gold quality |
| blood | UBERON:0000178 | 29.16 | gold quality |
| muscle of leg | UBERON:0001383 | 28.92 | gold quality |
| tonsil | UBERON:0002372 | 28.90 | gold quality |
| gastrocnemius | UBERON:0001388 | 28.60 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| heart left ventricle | UBERON:0002084 | 26.65 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| leukocyte | CL:0000738 | 26.20 | gold quality |
| monocyte | CL:0000576 | 26.06 | gold quality |
| pancreas | UBERON:0001264 | 26.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting KRTAP2-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-4527 | 99.66 | 67.43 | 714 |
| HSA-MIR-6503-5P | 99.62 | 66.96 | 597 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-3194-3P | 98.83 | 66.22 | 1167 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-3184-5P | 98.56 | 67.13 | 1491 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-561-5P | 98.25 | 68.13 | 1365 |
| HSA-MIR-3166 | 98.24 | 66.63 | 1223 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-9851-5P | 97.57 | 67.49 | 1067 |
| HSA-MIR-1289 | 97.46 | 65.37 | 655 |
| HSA-MIR-4433B-3P | 97.22 | 63.62 | 663 |
| HSA-MIR-610 | 96.84 | 67.98 | 905 |
| HSA-MIR-4652-5P | 96.46 | 64.22 | 553 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap5-2 | ENSMUSG00000054759 |
| mus_musculus | Krtap5-20 | ENSMUSG00000056885 |
| mus_musculus | Krtap5-26 | ENSMUSG00000109859 |
| mus_musculus | Krtap5-24 | ENSMUSG00000110324 |
| rattus_norvegicus | Krtap5-8 | ENSRNOG00000020131 |
| rattus_norvegicus | AABR07006049.1 | ENSRNOG00000046649 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 2-2 — Q9BYT5 (reviewed: Q9BYT5)
Alternative names: High sulfur keratin-associated protein 2.2, Keratin-associated protein 2.2
All UniProt accessions (1): Q9BYT5
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 2 family.
RefSeq proteins (1): NP_149021* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
| IPR052154 | KRTAP_type_2-like | Family |
Pfam: PF01500
UniProt features (3 total): chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYT5-F1 | 33.11 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 5 (showing top):
REACTOME_KERATINIZATION, MIR3619_5P, MIR4709_3P, chr17q21, ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP2-2 | TBC1D3K | A0A087X1G2 | 590 |
| KRTAP2-2 | KRTAP22-1 | Q3MIV0 | 580 |
| KRTAP2-2 | KRTAP8-1 | Q8IUC2 | 518 |
| KRTAP2-2 | KRTAP13-3 | Q3SY46 | 518 |
| KRTAP2-2 | TBC1D3H | P0C7X1 | 512 |
| KRTAP2-2 | ARHGEF33 | A8MVX0 | 507 |
| KRTAP2-2 | KRTAP6-1 | Q3LI64 | 505 |
| KRTAP2-2 | KRTAP21-2 | Q3LI59 | 505 |
| KRTAP2-2 | TBC1D3D | A0A087WVF3 | 478 |
| KRTAP2-2 | KRTAP24-1 | Q3LI83 | 477 |
| KRTAP2-2 | FRMD1 | Q8N878 | 468 |
| KRTAP2-2 | SPRR4 | Q96PI1 | 447 |
| KRTAP2-2 | KRTAP4-3 | Q9BYR4 | 447 |
| KRTAP2-2 | KRTAP3-2 | Q9BYR7 | 447 |
| KRTAP2-2 | KRTAP1-1 | Q07627 | 446 |
IntAct
0 interactions, top by confidence:
BioGRID (3): KRTAP2-2 (Negative Genetic), KRTAP2-2 (Affinity Capture-MS), KRTAP2-2 (Affinity Capture-MS)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: P02441, P02442, P02443, P0C7H8, Q9BYR9, Q9BYT5, Q9BYU5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
163 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41055000:T:A | donor_gain | 0.9100 |
| 17:41055170:G:C | donor_gain | 0.7500 |
| 17:41055025:A:T | donor_gain | 0.6600 |
| 17:41055163:C:A | donor_gain | 0.6600 |
| 17:41054854:T:TA | donor_gain | 0.6500 |
| 17:41054950:C:CT | donor_gain | 0.6400 |
| 17:41054898:TG:T | donor_gain | 0.6100 |
| 17:41055029:C:CT | donor_gain | 0.5900 |
| 17:41054843:G:C | donor_gain | 0.5800 |
| 17:41054947:A:T | donor_gain | 0.5800 |
| 17:41055030:G:T | donor_gain | 0.5700 |
| 17:41055026:C:T | donor_gain | 0.5600 |
| 17:41055162:C:A | donor_gain | 0.5600 |
| 17:41054524:T:TC | acceptor_gain | 0.5500 |
| 17:41054687:C:CA | donor_gain | 0.5300 |
| 17:41054808:TG:T | donor_gain | 0.5300 |
| 17:41054563:T:TA | donor_gain | 0.5100 |
| 17:41054584:T:C | donor_gain | 0.5100 |
| 17:41054764:T:TA | donor_gain | 0.5100 |
| 17:41054944:TGCAC:T | donor_gain | 0.5000 |
| 17:41054521:T:C | acceptor_gain | 0.4900 |
| 17:41055174:A:AC | donor_gain | 0.4900 |
| 17:41054753:G:C | donor_gain | 0.4700 |
| 17:41055001:C:A | donor_gain | 0.4500 |
| 17:41054515:T:TC | acceptor_gain | 0.4400 |
| 17:41054521:T:TC | acceptor_gain | 0.4300 |
| 17:41054583:AT:A | donor_gain | 0.4300 |
| 17:41054524:T:C | acceptor_gain | 0.4200 |
| 17:41054654:T:TA | donor_gain | 0.4200 |
| 17:41054948:C:T | donor_gain | 0.4200 |
AlphaMissense
783 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41054947:A:G | C89R | 0.936 |
| 17:41054930:C:A | W94C | 0.926 |
| 17:41054930:C:G | W94C | 0.926 |
| 17:41054977:A:G | C79R | 0.922 |
| 17:41054945:G:C | C89W | 0.910 |
| 17:41054982:A:G | I77T | 0.901 |
| 17:41054982:A:C | I77S | 0.898 |
| 17:41054982:A:T | I77N | 0.888 |
| 17:41054975:G:C | C79W | 0.885 |
| 17:41054946:C:T | C89Y | 0.881 |
| 17:41054962:A:G | C84R | 0.876 |
| 17:41054946:C:G | C89S | 0.872 |
| 17:41054947:A:T | C89S | 0.872 |
| 17:41055099:G:A | T38I | 0.872 |
| 17:41054932:A:G | W94R | 0.865 |
| 17:41054932:A:T | W94R | 0.865 |
| 17:41054972:G:C | C80W | 0.862 |
| 17:41054995:A:G | C73R | 0.850 |
| 17:41054933:G:C | C93W | 0.846 |
| 17:41054976:C:T | C79Y | 0.845 |
| 17:41054936:G:C | C92W | 0.843 |
| 17:41054935:A:G | C93R | 0.841 |
| 17:41054960:G:C | C84W | 0.839 |
| 17:41054998:C:G | G72R | 0.827 |
| 17:41055088:G:T | R42S | 0.817 |
| 17:41054976:C:G | C79S | 0.815 |
| 17:41054977:A:T | C79S | 0.815 |
| 17:41054993:G:C | C73W | 0.814 |
| 17:41055011:G:C | C67W | 0.813 |
| 17:41055023:G:C | C63W | 0.806 |
dbSNP variants (sampled 300 via entrez): RS1001235895 (17:41054541 T>A,C,G), RS1002352905 (17:41054262 T>A), RS1002904641 (17:41056250 A>C), RS1003560410 (17:41054144 G>A,T), RS1004959534 (17:41055596 A>C,G), RS1006380706 (17:41055233 G>A,C), RS1008925501 (17:41054598 G>C), RS1009631008 (17:41056307 G>A), RS1009705958 (17:41056504 C>A,G,T), RS1011034652 (17:41054558 T>C), RS1011440190 (17:41056395 G>A,T), RS1011520998 (17:41054784 G>T), RS1011747338 (17:41056884 A>C,G), RS1011803350 (17:41056261 C>G,T), RS1012168389 (17:41054155 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| mancozeb | decreases expression | 1 |
| Arsenic | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Smoke | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Genistein | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.